Loyens & Loeff is known for handling a broad range of matters in the healthcare and life sciences arena, including advising on clinical trials, investments, procurement cases and competition issues. Kim Lucassen leads the firm's data protection and privacy practice and is active in life sciences and healthcare matters; she co-heads the department with Vincent van der Lans, a key contact for M&A work and multi-jurisdictional restructurings, and the 'highly skilled' Tom van Helmond, who handles a wide spectrum of procurement and competition law issues. Dieuwke Hooft Graafland's 'knowledge of legislation in her field of expertise is remarkable'. Hamza Zourakhti left the firm in September 2024.
L’éditorial du Legal 500

Témoignages

Collectés indépendamment par l'équipe de recherche du Legal 500.

  • ‘Dieuwke Hooft-Graafland's knowledge of legislation in her field of expertise is remarkable.’

  • ‘Loyens & Loeff provides a high quality of service. The lawyers are specialists in their field.’

  • ‘The team is highly knowledgeable in healthcare and life sciences.’

  • ‘The experts at Loyens & Loeff are accessible, committed, trustworthy and effective. Tom van Helmond and Dieuwke Hooft Graafland are outstanding.’

  • ‘Dieuwke Hooft Graafland is a great lawyer. She is very experienced and keeps her eye on the bigger picture. She delivers on time.’

  • ‘The Healthcare and Life Sciences practice has consistently demonstrated a deep understanding of the unique challenges and opportunities within the life sciences and healthcare industry, offering tailored advice that balances legal expertise with industry knowledge. Their multidisciplinary team combines legal, regulatory, and tax expertise, enabling them to provide integrated solutions that address the full spectrum of challenges in healthcare and life sciences. They have a strong track record of navigating complex regulatory environments, both at national and EU levels.'

  • ‘Tom van Helmond is a highly skilled expert within the Healthcare and Life Sciences team, and what truly makes him exceptional is his combination of technical legal expertise and a deep understanding of the intricacies of the industry. What makes Tom different from others in the field is his commitment to truly understanding his clients' needs. He doesn’t just provide legal advice; he takes the time to learn the nuances of your business and the sector in which you operate, ensuring that his counsel is practical and directly applicable to your goals.'

Clients clés

  • AstraZeneca
  • Zilveren Kruis
  • Unilabs
  • Bergman Clinics
  • Zorgverzekeraars Nederland
  • European Investment Bank
  • Forbion
  • VGZ
  • Laurens
  • Unilabs

Points forts

  • Advised Eurazeo S.A on the sale of medical technology company DORC to German company Carl Zeiss Meditec AG.
  • Advising healthcare insurers on a range of legal matters concerning the bankruptcy of Co-Med.
  • Advised the Orpea Group on restructuring and healthcare regulatory aspects in the Netherlands.

Avocats

Hall of Fame

Avocats au sommet de leur profession, largement reconnus et respectés par l'ensemble du marché pour leur expertise éprouvée et leur intervention récurrente et longue date dans les dossiers les plus complexes et prestigieux.

Meilleurs collaborateurs

Jeunes avocats collaborateurs ou counsels qui se distinguent régulièrement par leur présence dans des dossiers importants du marché, et qui sont identifiés par le marché comme de jeunes talents à suivre.

Responsable de la pratique

Tom van Helmond; Kim Lucassen; Vincent van der Lans

Autres avocats clés

Dieuwke Hooft Graafland; Aurélie Mingels